Mel,
All of the studies you and George are citing do not tell you what you need to know: is there any benefit to survival of irradiating a limited number of pelvic lymph nodes? To know that, you would have to have (1) a control group in which you didn't do this, and (2) a longer term study to understand the effect over time. There have been no controlled studies to date, although there are some in clinical trials. The studies so far have been very small, limited time, and uncontrolled.
Here's an article about
a meta-analysis that tried to accumulate data from several studies. The data are sobering:after the kind of treatment you are considering, 69% nevertheless had distant mets detected within 3 years, and 85% within 5 years. The second from last paragraph is particularly applicable to you.
I said...
Because most of the detected oligometastases were in the pelvic lymph nodes, there is a special opportunity for lymph node-only treatment. Arguably, the entire pelvic lymph node area, and not just individual detected nodes, ought to be treated, and this was done in about 40% of the cases. There may be micrometastases that are too small to be detected in the pelvic lymph system. That area is typically not treated during primary radiation therapy, or during adjuvant/salvage radiation treatment. It may, in some cases, be amenable to additional radiation if previous treatment was not too wide, was long ago, and anatomic considerations (e.g., visceral fat) allow for it. Recent analyses by Rusthoven et al. and by Abdollah et al. found a survival benefit to such whole pelvic salvage radiation (type unspecified), but Kaplan et al. failed to find a benefit. Salvage SBRT whole pelvic treatment for recurrent patients with positive nodes has yet to be explored in sufficient numbers of patients to draw conclusions about it.
SBRT for Oligometastatic Recurrence